Literature DB >> 9541375

The interaction of patient perception of overmedication with drug compliance and side effects.

B G Fincke1, D R Miller, A Spiro.   

Abstract

OBJECTIVE: Little is known about the significance of patient-perceived overmedication. We sought to determine its prevalence and relation to medication compliance, adverse drug reactions, health-related quality of life (HRQOL), and burden of illness.
DESIGN: Analysis of self-reported questionnaire data. PATIENTS/PARTICIPANT: There were 1,648 participants in a longitudinal study of male veterans. INTERVENTION: Participants listed each of their medications with indication, missed doses, adverse reactions, and whether their amount of medication was "too much, the right amount, or too little." The survey included questions about medication adherence, "problems with medications," common symptoms, and screening questions for a number of chronic conditions. We assessed HRQOL with the Multiple Outcomes Study 36-Item Short Form Health Study (SF-36).
MEASUREMENTS AND MAIN RESULTS: Of the 1,256 respondents, 1,007 (80%) had taken medication within 4 weeks. Forty (4%) thought they were taking too much. They reported a 1.6-fold increase in prescription medications, a 5-8 fold increase in adverse effects, a 1.5-2 fold decrease in compliance, an increase in each of seven measured symptoms, and a decrease in six of eight SF-36 domains (p < .05 for all comparisons), the exceptions being the mental health and role-emotional scales. There was also a slight increase in the report of any chronic illness (95% vs 86%, p > .05).
CONCLUSIONS: Patient perception of overmedication correlates with self-report of decreased compliance, adverse drug reactions, decreased HRQOL, and an increase in symptomatology that is compatible with unrecognized side effects of medication. Such patients warrant careful evaluation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541375      PMCID: PMC1496921          DOI: 10.1046/j.1525-1497.1998.00053.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  10 in total

1.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

2.  An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.

Authors:  M S Kramer; J M Leventhal; T A Hutchinson; A R Feinstein
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

3.  Drug-induced illness leading to hospitalization.

Authors:  G J Caranasos; R B Stewart; L E Cluff
Journal:  JAMA       Date:  1974-05-06       Impact factor: 56.272

4.  Drug therapy: patient compliance.

Authors:  B Blackwell
Journal:  N Engl J Med       Date:  1973-08-02       Impact factor: 91.245

5.  Drug-related admissions to a family medicine inpatient service.

Authors:  T J Ives; E J Bentz; R E Gwyther
Journal:  Arch Intern Med       Date:  1987-06

6.  Methods in assessing drug compliance.

Authors:  S E Norell
Journal:  Acta Med Scand Suppl       Date:  1984

7.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

8.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

9.  Can simple clinical measurements detect patient noncompliance?

Authors:  R B Haynes; D W Taylor; D L Sackett; E S Gibson; C D Bernholz; J Mukherjee
Journal:  Hypertension       Date:  1980 Nov-Dec       Impact factor: 10.190

10.  Screening for noncompliance among patients with hypertension: is self-report the best available measure?

Authors:  T S Inui; W B Carter; R E Pecoraro
Journal:  Med Care       Date:  1981-10       Impact factor: 2.983

  10 in total
  24 in total

1.  Identifying and reducing complications of outpatient medications.

Authors:  B G Petty
Journal:  J Gen Intern Med       Date:  2000-03       Impact factor: 5.128

2.  Intentional and unintentional nonadherence: a study of decision making.

Authors:  Abigail L Wroe
Journal:  J Behav Med       Date:  2002-08

3.  The epidemiology of polypharmacy.

Authors:  Rupert A Payne
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

4.  Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.

Authors:  Rupert A Payne; Gary A Abel; Anthony J Avery; Stewart W Mercer; Martin O Roland
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

5.  Amending iPLEDGE: Why "Abstaining from Abstinence" May Harm LGBTQ+ Patients.

Authors:  Kanika Kamal; Alexandra Charrow; Avery LaChance
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

6.  Prevalence of polypharmacy in a Scottish primary care population.

Authors:  R A Payne; A J Avery; M Duerden; C L Saunders; C R Simpson; G A Abel
Journal:  Eur J Clin Pharmacol       Date:  2014-02-01       Impact factor: 2.953

Review 7.  More medications, fewer pills: combination medications for the treatment of hypertension.

Authors:  Richard Lewanczuk; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

8.  "It's just routine." A qualitative study of medicine-taking amongst older people in New Zealand.

Authors:  June Tordoff; Kirsten Simonsen; W Murray Thomson; Pauline T Norris
Journal:  Pharm World Sci       Date:  2009-12-31

Review 9.  Adherence to medication in patients with dementia: predictors and strategies for improvement.

Authors:  Sönke Arlt; Reinhard Lindner; Alexander Rösler; Wolfgang von Renteln-Kruse
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 10.  Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.

Authors:  Thomas Mengden; Sakir Uen; Peter Bramlage
Journal:  Vasc Health Risk Manag       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.